PANBELA THERAPEUTICS INC (PBLA) 1.53 +0.1 (+6.99%)

1.53 +0.1 (+6.99%)

US69833W1071 - Common Stock - After market: 1.91 +0.38 (+24.84%)

Analysts have set a mean price target of 387.6. This target is 25233.33% above the current price.

PBLA was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PBLA.

In the previous month the buy percentage consensus was at a similar level.

PBLA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price

Low

Median

Mean

High

1.53

242.40

387.60

546.00

15,743.14%

25,233.33%

35,586.27%

Date	Firm	Action	Rating
2022-10-12	Maxim Group	Downgrade	Buy -> Hold
2021-06-28	Roth Capital	Initiate	Buy
2021-03-10	Maxim Group	Initiate	Buy

Find the competitors with the best analyst ratings on the USA